Lesser ML

Title : Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial - Consolim-Colombo_2017_JCI.Insight_2_

Author(s) : Consolim-Colombo FM , Sangaleti CT , Costa FO , Morais TL , Lopes HF , Motta JM , Irigoyen MC , Bortoloto LA , Rochitte CE , Harris YT , Satapathy SK , Olofsson PS , Akerman M , Chavan SS , MacKay M , Barnaby DP , Lesser ML , Roth J , Tracey KJ , Pavlov VA

Ref : JCI Insight , 2 : , 2017

Abstract :

PubMedSearch : Consolim-Colombo_2017_JCI.Insight_2_

PubMedID: 28724799

Title : Safety of direct administration of AAV2(CU)hCLN2, a candidate treatment for the central nervous system manifestations of late infantile neuronal ceroid lipofuscinosis, to the brain of rats and nonhuman primates - Hackett_2005_Hum.Gene.Ther_16_1484

Author(s) : Hackett NR , Redmond DE , Sondhi D , Giannaris EL , Vassallo E , Stratton J , Qiu J , Kaminsky SM , Lesser ML , Fisch GS , Rouselle SD , Crystal RG

Ref : Hum Gene Therapy , 16 :1484 , 2005

Abstract :

PubMedSearch : Hackett_2005_Hum.Gene.Ther_16_1484

PubMedID: 16390279

Lesser ML

References (2)

1. Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial - Consolim-Colombo_2017_JCI.Insight_2_

2. Safety of direct administration of AAV2(CU)hCLN2, a candidate treatment for the central nervous system manifestations of late infantile neuronal ceroid lipofuscinosis, to the brain of rats and nonhuman primates - Hackett_2005_Hum.Gene.Ther_16_1484